NO830686L - Fremgangsmaate for fremstilling av erytromycinderivater - Google Patents

Fremgangsmaate for fremstilling av erytromycinderivater

Info

Publication number
NO830686L
NO830686L NO830686A NO830686A NO830686L NO 830686 L NO830686 L NO 830686L NO 830686 A NO830686 A NO 830686A NO 830686 A NO830686 A NO 830686A NO 830686 L NO830686 L NO 830686L
Authority
NO
Norway
Prior art keywords
preparation
hydrogen
procedure
considered
erythromycin derivatives
Prior art date
Application number
NO830686A
Other languages
English (en)
Other versions
NO155932C (no
NO155932B (no
Inventor
Frank Christian Sciavolino
Mark Alan Guadliana
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO830686L publication Critical patent/NO830686L/no
Publication of NO155932B publication Critical patent/NO155932B/no
Publication of NO155932C publication Critical patent/NO155932C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
NO830686A 1982-03-01 1983-02-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive erytromycin-derivater. NO155932C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/353,547 US4382085A (en) 1982-03-01 1982-03-01 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents

Publications (3)

Publication Number Publication Date
NO830686L true NO830686L (no) 1983-09-02
NO155932B NO155932B (no) 1987-03-16
NO155932C NO155932C (no) 1987-06-24

Family

ID=23389603

Family Applications (1)

Application Number Title Priority Date Filing Date
NO830686A NO155932C (no) 1982-03-01 1983-02-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive erytromycin-derivater.

Country Status (26)

Country Link
US (1) US4382085A (no)
EP (1) EP0087905B1 (no)
JP (1) JPS58159499A (no)
KR (1) KR850000965B1 (no)
AT (1) ATE15048T1 (no)
AU (1) AU555208B2 (no)
CA (1) CA1178596A (no)
CS (3) CS235036B2 (no)
DD (1) DD211565A5 (no)
DE (1) DE3360589D1 (no)
DK (1) DK157495C (no)
EG (1) EG16630A (no)
ES (2) ES8403928A1 (no)
FI (1) FI74287C (no)
GR (1) GR78094B (no)
GT (1) GT198301599A (no)
HU (1) HU193157B (no)
IE (1) IE56056B1 (no)
IL (1) IL68004A (no)
NO (1) NO155932C (no)
NZ (1) NZ203417A (no)
PH (1) PH17908A (no)
PL (1) PL138758B1 (no)
PT (1) PT76298B (no)
RO (1) RO86647B (no)
ZA (1) ZA831356B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
GR80277B (en) * 1983-09-06 1985-01-04 Pfizer Azahomoerythromycin b derivatives and intermediates therefor
JPS60120895A (ja) * 1983-12-02 1985-06-28 Taisho Pharmaceut Co Ltd ６−０−メチル−２′−０，ν−ビス（ベンジルオキシカルボニル）−ν−デメチルエリスロマイシンａの製法
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
US4783811A (en) * 1984-12-27 1988-11-08 Texas Instruments Incorporated Method and apparatus for determining syllable boundaries
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
US4681872A (en) * 1985-11-12 1987-07-21 Abbott Laboratories Erythromycin A 11,12-carbonate and method of use
US4833236A (en) * 1986-05-02 1989-05-23 Taisho Pharmaceutical Co., Ltd. Erythromycin derivatives
ATE154806T1 (de) * 1993-05-19 1997-07-15 Pfizer Zwischenprodukt für azithromycin
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
CN100363359C (zh) * 2002-08-29 2008-01-23 菲塞股份有限公司 运动内酯化合物
WO2004101592A1 (ja) * 2003-05-19 2004-11-25 Taisho Pharmaceutical Co., Ltd. エリスロマイシンａ誘導体の製造方法
US7211568B2 (en) * 2003-12-18 2007-05-01 Kosan Biosciences Incorporated 9-Desoxoerythromycin compounds as prokinetic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3417077A (en) * 1966-05-16 1968-12-17 Lilly Co Eli Erythromycin derivative and process for the preparation thereof
US3884904A (en) * 1973-06-21 1975-05-20 Abbott Lab 11-Substituted erythromycin B derivatives
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
SE445223B (sv) * 1977-02-04 1986-06-09 Pfizer Sett att framstella 4"-amino-erytomylin-a-derivat
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives

Also Published As

Publication number Publication date
IE56056B1 (en) 1991-04-10
ES8602837A1 (es) 1985-11-16
CS235048B2 (en) 1985-04-16
DK157495B (da) 1990-01-15
JPH0140039B2 (no) 1989-08-24
KR840003647A (ko) 1984-09-15
PT76298B (en) 1986-01-27
IL68004A (en) 1986-11-30
FI830654A0 (fi) 1983-02-28
FI830654L (fi) 1983-09-02
DK157495C (da) 1990-06-11
US4382085A (en) 1983-05-03
FI74287B (fi) 1987-09-30
NO155932C (no) 1987-06-24
CS235036B2 (en) 1985-04-16
EP0087905A1 (en) 1983-09-07
IL68004A0 (en) 1983-06-15
DK96783A (da) 1983-09-02
DE3360589D1 (en) 1985-09-26
CS235049B2 (en) 1985-04-16
DD211565A5 (de) 1984-07-18
IE830411L (en) 1983-09-01
GR78094B (no) 1984-09-26
RO86647A (ro) 1985-04-17
AU1189883A (en) 1983-09-08
HU193157B (en) 1987-08-28
KR850000965B1 (ko) 1985-07-02
NO155932B (no) 1987-03-16
NZ203417A (en) 1985-10-11
PL138758B1 (en) 1986-10-31
PT76298A (en) 1983-03-01
RO86647B (ro) 1985-05-01
ZA831356B (en) 1983-11-30
ES520177A0 (es) 1984-04-01
ATE15048T1 (de) 1985-09-15
PL240764A1 (en) 1985-01-02
EG16630A (en) 1991-03-30
GT198301599A (es) 1984-09-13
ES526323A0 (es) 1985-11-16
FI74287C (fi) 1988-01-11
DK96783D0 (da) 1983-02-28
ES8403928A1 (es) 1984-04-01
EP0087905B1 (en) 1985-08-21
PH17908A (en) 1985-01-25
AU555208B2 (en) 1986-09-18
JPS58159499A (ja) 1983-09-21
CA1178596A (en) 1984-11-27

Similar Documents

Publication Publication Date Title
NO830686L (no) Fremgangsmaate for fremstilling av erytromycinderivater
ATE69055T1 (de) 19,11beta-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate.
ES476109A1 (es) Procedimiento para la preparacion de derivados de cefalospo-rina
AU558261B2 (en) Dialkylaminoalkyoxybenzylalcohol derivatives
ES480112A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
DE3461378D1 (en) Rifamycins derivatives and preparation and pharmaceutical compositions thereof
ZA794155B (en) New aminoglycosides derived from desoxystreptamine,and their salts,their preparation process,their application as medicaments and the pharmaceutical compounds containing them
ES473415A1 (es) Un procedimiento para la preparacion de derivados de tiena- micina
DE3569538D1 (en) Novel antibiotics, process for their preparation and pharmaceutical compositions containing them
AU567498B2 (en) 5-phenyl-1h-2,3-dihydro-1,4-benzodiazepine derivatives.
HU901631D0 (en) Process for the preparation of thienyl-piperazine derivatives and pharmaceutical compositions containing them
AU7993982A (en) Tetra-peptide
FI873365A (fi) Foerfarande foer framstaellning av nya fosfo-foereningar.

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN FEBRUARY 2003